2015-2019年美国主动细菌核心监测(ABCs)系统中播散性淋球菌感染的监测
通过主动细菌核心监测系统,2015-2016年在2个监测区回顾性、2017-2019年在3个监测区前瞻性监测培养确诊的播散性淋球菌感染(DGI)。2015-2019年共发现77例DGI,发病率为0.13例/10万人口,占3个监测区所有报告淋病病例的0.06%。2017-2019年29株分离株均对头孢曲松敏感。
要点
- DGI发病率为0.13例/10万人口,占报告淋病病例的0.06%。
- 多数DGI病例为男性(64%)、非西班牙裔黑人(68%),年龄16至67岁。
- 血液(55%)和关节(40%)是最常见的无菌部位。
核心结论
- DGI是淋病奈瑟菌不常见的并发症;因其可快速出现抗菌药物耐药,持续DGI监测包括监测抗菌药物敏感性趋势,有助于为DGI治疗建议提供信息。
研究设计与样本
- 2015-2016年在2个ABCs监测区居民中开展回顾性监测,2017-2019年在3个ABCs监测区开展前瞻性监测。
- DGI病例定义为从正常无菌部位分离出淋病奈瑟菌;对每例病例填写病例报告表,并对可用分离株进行抗菌药物敏感性试验(AST)。
主要发现
- 2015-2019年共发现77例DGI病例,发病率为0.13例/10万人口,占3个监测区所有报告淋病病例的0.06%。
- 多数DGI病例为男性(64%)、非西班牙裔黑人(68%),年龄范围为16至67岁。
- 血液(55%)和关节(40%)是最常见的无菌部位。
- 2017-2019年29株有AST结果的分离株均对头孢曲松敏感。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disseminated gonococcal infections (DGIs) are thought to be uncommon; surveillance is limited, and case reports are analyzed retrospectively or in case clusters. We describe the population-level burden of culture-confirmed DGIs through the Active Bacterial Core surveillance (ABCs) system. METHODS: During 2015-2016, retrospective surveillance was conducted among residents in 2 ABCs areas and prospectively in 3 ABCs areas during 2017-2019. A DGI case was defined as isolation of Neisseria gonorrhoeae from a normally sterile site. A case report form was completed for each case and antimicrobial susceptibility testing (AST) was performed on available isolates. RESULTS: During 2015-2019, 77 DGI cases were identified (a rate of 0.13 cases per 100 000 population) and accounted for 0.06% of all reported gonorrhea cases in the 3 surveillance areas. Most DGI cases were male (64%), non-Hispanic Black (68%), and ranged from 16 to 67 years of age; blood (55%) and joint (40%) were the most common sterile sites. Among 29 isolates with AST results during 2017-2019, all were susceptible to ceftriaxone. CONCLUSIONS: DGI is an infrequent complication of N gonorrhoeae; because it can quickly develop antimicrobial resistance, continued DGI surveillance, including monitoring trends in antimicrobial susceptibility, could help inform DGI treatment recommendations.
引用
- Weston EJ, Heidenga BL, Farley MM, et al. Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core Surveillance (ABCs)-United States, 2015-2019. Clin Infect Dis. 2022. PMID: 35090024. doi:10.1093/cid/ciac052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。